Carregant...
Host MyD88 signaling protects against acute graft‐versus‐host disease after allogeneic bone marrow transplantation
Recent experimental strategies to reduce graft‐versus‐host disease (GVHD) have focused largely on modifying innate immunity. Toll‐like receptor (TLR)‐driven myeloid differentiation primary response 88 (MyD88)‐dependent signalling pathways that initiate adaptive immune function are also critical for...
Guardat en:
| Publicat a: | Clin Exp Immunol |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley and Sons Inc.
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6300651/ https://ncbi.nlm.nih.gov/pubmed/30317551 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cei.13215 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|